AUPH icon

Aurinia Pharmaceuticals

11 hedge funds and large institutions have $30.7M invested in Aurinia Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
2
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMC
1
NEA Management Company
Maryland
$9.27M 2,546,843
RCM
2
RA Capital Management
Massachusetts
$9.01M 2,474,076 +2,474,076 New
GPP
3
Great Point Partners
Connecticut
$8.88M 2,485,576 +11,500 +0.5%
BBA
4
Baker Bros. Advisors
New York
$2.6M 727,669
Deutsche Bank
5
Deutsche Bank
Germany
$485K 133,333
CCMU
6
Cheyne Capital Management (UK)
United Kingdom
$323K 90,000 -16,805 -16%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$46K 12,500
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$41K 11,365 -2,086 -16%
TRCT
9
Tower Research Capital (TRC)
New York
$11K 3,048 +1,448 +91%
Citigroup
10
Citigroup
New York
$1K 171 +171 New
Morgan Stanley
11
Morgan Stanley
New York
$0 53